Lacticaseibacillus rhamnosus Lcr35 Stimulates Epithelial Vaginal Defenses upon Gardnerella vaginalis Infection.


Journal

Infection and immunity
ISSN: 1098-5522
Titre abrégé: Infect Immun
Pays: United States
ID NLM: 0246127

Informations de publication

Date de publication:
15 09 2022
Historique:
pubmed: 25 8 2022
medline: 20 9 2022
entrez: 24 8 2022
Statut: ppublish

Résumé

Dysbiosis of the vaginal microbiome as a result of overgrowth of anaerobic bacteria, such as Gardnerella vaginalis, and low levels of "healthy" lactobacilli leads to bacterial vaginosis (BV), usually associated with a low-grade inflammatory process. Despite appropriate antibiotic treatment,

Identifiants

pubmed: 36000874
doi: 10.1128/iai.00309-22
pmc: PMC9476927
doi:

Substances chimiques

Anti-Bacterial Agents 0
Chemokines 0
Cytokines 0
Interleukin-8 0
Secretory Leukocyte Peptidase Inhibitor 0
beta-Defensins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0030922

Références

Infect Dis Obstet Gynecol. 2008;2008:549640
pubmed: 19190778
Microbes Infect. 2008 Apr;10(4):439-46
pubmed: 18403235
Eur J Clin Microbiol Infect Dis. 2018 Oct;37(10):1869-1880
pubmed: 30032443
J Biol Chem. 2002 Sep 13;277(37):33648-53
pubmed: 12084717
Obstet Gynecol. 2007 Jan;109(1):114-20
pubmed: 17197596
Sci Rep. 2020 Apr 10;10(1):6196
pubmed: 32277092
Sci Rep. 2021 Nov 29;11(1):23069
pubmed: 34845288
J Biomed Sci. 2012 Jun 20;19:58
pubmed: 22715972
J Infect Dis. 1997 Sep;176(3):728-39
pubmed: 9291322
Curr Infect Dis Rep. 2004 Dec;6(6):450-456
pubmed: 15538982
Curr Opin Gastroenterol. 2007 Nov;23(6):679-92
pubmed: 17906447
BMC Infect Dis. 2015 Jul 29;15:292
pubmed: 26219949
Hum Reprod. 2005 May;20(5):1372-8
pubmed: 15695310
Infect Immun. 2005 Mar;73(3):1271-4
pubmed: 15731023
Infect Immun. 2006 Oct;74(10):5693-702
pubmed: 16988245
Clin Vaccine Immunol. 2007 Sep;14(9):1102-7
pubmed: 17671228
Sci Rep. 2020 Oct 13;10(1):17074
pubmed: 33051479
J Infect Dis. 2006 Jun 1;193(11):1478-86
pubmed: 16652274
Cytokine Growth Factor Rev. 2021 Jun;59:22-35
pubmed: 33602652
Res Microbiol. 2001 Mar;152(2):167-73
pubmed: 11316370
Front Immunol. 2020 Aug 04;11:1655
pubmed: 32849571
Arch Gynecol Obstet. 2010 Jan;281(1):77-80
pubmed: 19365635
Probiotics Antimicrob Proteins. 2014 Dec;6(3-4):165-76
pubmed: 25028263
Annu Rev Microbiol. 2012;66:371-89
pubmed: 22746335
Cytokine Growth Factor Rev. 2016 Apr;28:79-93
pubmed: 26718149
Am J Obstet Gynecol. 1993 Aug;169(2 Pt 2):441-5
pubmed: 8357040
Hum Reprod Update. 2015 May-Jun;21(3):353-77
pubmed: 25547201
Mol Hum Reprod. 2003 Jan;9(1):53-8
pubmed: 12529421
Jpn J Infect Dis. 2020 May 22;73(3):214-220
pubmed: 31875602
Benef Microbes. 2018 Jan 29;9(1):87-100
pubmed: 29022382
Microbes Infect. 2005 Jul;7(9-10):1117-27
pubmed: 15893496
PLoS One. 2013;8(3):e59539
pubmed: 23527214
Front Microbiol. 2018 Jun 15;9:1278
pubmed: 29963028
Infect Dis Obstet Gynecol. 2012;2012:503648
pubmed: 22701297
Curr HIV Res. 2012 Apr;10(3):202-10
pubmed: 22384839
J Infect Dis. 2000 Aug;182(2):467-73
pubmed: 10915077
Front Cell Infect Microbiol. 2020 Feb 28;10:71
pubmed: 32257961
Infect Immun. 2004 Jun;72(6):3684-7
pubmed: 15155685
J Infect Dis. 2002 Jun 1;185(11):1614-20
pubmed: 12023767
Immunol Lett. 2013 Nov-Dec;156(1-2):102-9
pubmed: 24120511
J Exp Med. 2005 Dec 19;202(12):1659-68
pubmed: 16352738
Immunol Invest. 2010;39(4-5):429-48
pubmed: 20450286
BMC Microbiol. 2013 Jan 08;13:4
pubmed: 23298379
Virulence. 2010 Sep-Oct;1(5):440-64
pubmed: 21178486
Int J Food Microbiol. 2009 Apr 30;131(1):40-51
pubmed: 19264370
BJOG. 2008 Oct;115(11):1369-74
pubmed: 18823487
Microb Cell Fact. 2020 Nov 7;19(1):203
pubmed: 33160356
Cochrane Database Syst Rev. 2009 Oct 07;(4):CD006289
pubmed: 19821358
Front Cell Infect Microbiol. 2021 Apr 07;11:631972
pubmed: 33898328
Am J Reprod Immunol. 2012 Aug;68(2):116-27
pubmed: 22537232

Auteurs

Sylvie Miquel (S)

Université Clermont Auvergne, UMR CNRS 6023 LMGE, Laboratoire de Bactériologie, Clermont-Ferrand, France.

Julien Verlaguet (J)

Université Clermont Auvergne, UMR CNRS 6023 LMGE, Laboratoire de Bactériologie, Clermont-Ferrand, France.

Sophie Garcin (S)

Université Clermont Auvergne, INRA, UNH, Unité de Nutrition Humaine, Laboratoire d'Immunologie, Clermont-Ferrand, France.

Thomas Bertran (T)

Université Clermont Auvergne, INRA, UNH, Unité de Nutrition Humaine, Laboratoire d'Immunologie, Clermont-Ferrand, France.

Bertrand Evrard (B)

Université Clermont Auvergne, INRA, UNH, Unité de Nutrition Humaine, Laboratoire d'Immunologie, Clermont-Ferrand, France.
CHU Clermont-Ferrand, Service d' Immunologie, Clermont-Ferrand, France.

Christiane Forestier (C)

Université Clermont Auvergne, UMR CNRS 6023 LMGE, Laboratoire de Bactériologie, Clermont-Ferrand, France.

Marjolaine Vareille-Delarbre (M)

Université Clermont Auvergne, UMR CNRS 6023 LMGE, Laboratoire de Bactériologie, Clermont-Ferrand, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH